Zacks Investment Research downgraded shares of BACTERIN INTL (BONE) from NEUTRAL to UNDERPERFORM on March 28, 2013, with a target price of $0.80.
Bacterin International, Inc. operates as a medical device company and accredited tissue bank that engages in the research, development, manufacture, and commercialization of bioactive coatings for medical devices. The Company's Biologic division offer OsteoSponge, OsteoWrap, OsteoSelect, OsteoLock, BacFast, Sports Medicine and traditional allografts. This division of Bacterin International focuses on the design and development of an allograft portfolio to meet the needs of the Spine, Cranio-maxillofacial, reconstructive, and trauma markets. The Coatings/Medical Devices Division develops medical devices intended for use in several diverse clinical areas including orthopedic, plastic, and cardiovascular surgery. Bacterin International, Inc. is based in Belgrade, Montana.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on BACTERIN INTL (BONE),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment